1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Aerie Pharmaceuticals Inc (AERI)
  7. Balanços

Aerie Pharmaceuticals Inc. (AERI) Fundamentals
Aerie Pharmaceuticals Inc is a clinical-stage pharmaceutical company. It is focused on the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, ocular surface diseases, and retinal diseases. Its main products are Rhopressa and Roklatan. The company mainly operates in North America.
SHARE INFORMATION
Market CapUS$ 574.549.387
Shares Outstanding49.359.913
Float48.313.153
Percent Float97,88%
Short Interest0,00
Short Percent Float0,0%
Short Interest Ratio0,00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0,00
Latest Fiscal RevenueUS$ 194.134.000
Latest Fiscal EPSUS$ -1,62
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)US$ 0,00
Dividend (5 Years)US$ 0,00
Ex Dividend Date-
Dividend RateUS$ 0,00
Dividend Yield0,0%
Payment Cash-
HOLDERS
Institutions377
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months7.099.522
Institutional Holdings Percent152,1%
Institutional Sold Previous 3 Months10.110.196
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months170.644
Insider Holdings Percent3,2
Insider Sold Previous 3 Months266
Insider Shares Owned1.548.184
TRADING INFO
52 Week HighUS$ 17,21
52 Week LowUS$ 4,81
52 Week High ChangeUS$ -19,56
21 Day Moving AverageUS$ 8,7857
21 Day Extended Moving AverageUS$ 9,4191
50 Day Moving AverageUS$ 7,9166
50 Day Extended Moving AverageUS$ 8,3859
200 Day Moving AverageUS$ 8,1181
200 Day Extended Moving AverageUS$ 8,8423
10 Day Average Volume932.339
20 Day Average Volume668.056
30 Day Average Volume594.075
50 Day Average Volume618.885
Alpha-0.024825
Beta0.3503
Standard Deviation0.158757
R20.012179
7 Day Price ChangeUS$ 0,41
7 Day Percent Change3,65%
21 Day Price ChangeUS$ 3,78
21 Day Percent Change48,09%
30 Day Price ChangeUS$ 3,67
30 Day Percent Change46,05%
Month to Date Price ChangeUS$ 4,63
Month to Date Percent Change66,05%
Quarter to Date Price ChangeUS$ 4,14
Quarter to Date Percent Change55,2%
180 Day Price ChangeUS$ 4,83
180 Day Percent Change70,93%
200 Day Price ChangeUS$ 4,72
200 Day Percent Change68,21%
Year to Date Price ChangeUS$ 4,62
Year to Date Percent Change65,81%

Aerie Pharmaceuticals Inc. (AERI) Key Ratios

PROFITABILITY
EBIT Margin-14,7%
EBITDA Margin-1,9%
Pre-Tax Profit Margin0,0%
Profit Margin Count-25,26%
Gross Margin88,2%
Profit Margin TOT-25,26%
INCOME STATEMENTS
RevenueUS$ 207.125.000
Revenue Per ShareUS$ 4,1962
Revenue (3 Years)US$ 0,00
Revenue (5 Years)US$ 0,00
FINANCIAL STRENGTH
Price to Tangible Book-4,10
Total Debt To Equity9,40
Int Coverage-1,70
Current Ratio2,60
Leverage Ratio-4,30
Quick Ratio2,10
Long Term Debt To Capital0,90
VALUATION MEASURES
PE Ratio-11,30
Enterprise ValueUS$ 732.407.378
Price to Sales2,7739
Price to Free Cash-112,30
PE High Last 5 Years-5,40
Price To Book34,30
Price To Cash Flow0,00
PE Low Last 5 Years-11,10
Price to Tangible Book-4,10
MANAGEMENT EFFECTIVENESS
Receivables Turnover3,40
Invoice Turnover0,70
Assets Turnover0,50
Return Assets-14,13
Return on Equity56,11
Return on Capital-21,84

Aerie Pharmaceuticals Inc. (AERI) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEORajkumar Kannan
Emplyoees376
Last AuditUQ
CIK0001337553
IndustryDrug Manufacturers
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address4301 Emperor Boulevard
Suite 400
Durham, NC 27703
Websitehttps://www.aeriepharma.com
Facsimile-
Telephone+1 919 237-5300
Emailabavishi@aeriepharma.com
Seu Histórico Recente
NASDAQ
AERI
Aerie Phar..
Registre-se agora para acompanhar essas ações ao vivo no Monitor ADVFN.

O Monitor permite ver até 110 de suas ações favoritas de uma vez só e é completamente grátis para você usar.

Faça o login em ADVFN
Registrar agora
Cotações da NYSE e AMEX têm defasagem de no mínimo 20 minutos.
Quaisquer outras cotações têm defasagem de no mínimo 15 minutos quando não especificado.
Em caso de dúvidas por favor entre em contato com o suporte: suporte@advfn.com.br ou (11) 4950 5808.

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

P: V:br D:20220817 19:53:41